Daiwa Securities Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-167
| Closed | -$3K | – | 1422 |
|
|
2023
Q3 | $3K | Hold |
167
| – | – | ﹤0.01% | 1206 |
|
|
2023
Q2 | $2K | Hold |
167
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q1 | $2K | Hold |
167
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q4 | $2K | Buy |
167
+105
| +169% | +$1.49K | ﹤0.01% | 1248 |
|
|
2022
Q3 | $1K | Hold |
62
| – | – | ﹤0.01% | 1327 |
|
|
2022
Q2 | $1K | Hold |
62
| – | – | ﹤0.01% | 1339 |
|
|
2022
Q1 | $1K | Hold |
62
| – | – | ﹤0.01% | 1362 |
|
|
2021
Q4 | $1K | Hold |
62
| – | – | ﹤0.01% | 1373 |
|
|
2021
Q3 | $1K | Hold |
62
| – | – | ﹤0.01% | 1295 |
|
|
2021
Q2 | $1K | Hold |
62
| – | – | ﹤0.01% | 1236 |
|
|
2021
Q1 | $1K | Hold |
62
| – | – | ﹤0.01% | 1247 |
|
|
2020
Q4 | $2K | Sell |
62
-123
| -66% | -$4.08K | ﹤0.01% | 1147 |
|
|
2020
Q3 | $8K | Hold |
185
| – | – | ﹤0.01% | 1062 |
|
|
2020
Q2 | $12K | Hold |
185
| – | – | ﹤0.01% | 1059 |
|
|
2020
Q1 | $12K | Hold |
185
| – | – | ﹤0.01% | 1050 |
|
|
2019
Q4 | $23K | Sell |
185
-20
| -10% | -$1.79K | ﹤0.01% | 1003 |
|
|
2019
Q3 | $14K | Hold |
205
| – | – | ﹤0.01% | 1016 |
|
|
2019
Q2 | $16K | Buy |
205
+16
| +8% | +$1.43K | ﹤0.01% | 1029 |
|
|
2019
Q1 | $21K | Sell |
189
-20
| -10% | -$2.19K | ﹤0.01% | 990 |
|
|
2018
Q4 | $21K | Buy |
209
+70
| +50% | +$7.26K | ﹤0.01% | 963 |
|
|
2018
Q3 | $18K | Hold |
139
| – | – | ﹤0.01% | 1007 |
|
|
2018
Q2 | $12K | Hold |
139
| – | – | ﹤0.01% | 1044 |
|
|
2018
Q1 | $9K | Buy |
+139
| New | +$8.38K | ﹤0.01% | 1038 |
|
Daiwa Securities Group's ICPT Position: Q4 2023 in Review
Daiwa Securities Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 167 shares — an estimated $3K sold.
Daiwa Securities Group first reported a position in ICPT in Q1 2018 and held it in 23 quarters. The position peaked at $23K in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Daiwa Securities Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Daiwa Securities Group sold 167 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $3K.
- Daiwa Securities Group first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2018 and held it in 23 quarters.
- Daiwa Securities Group's Intercept Pharmaceuticals, Inc. position peaked at $23K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.